Clinical Trial Update: A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction [Phase 2]

View source ↗

Summary

A Phase 2 trial of Spesolimab in fibrostenotic Crohn's disease was terminated. Results from the terminated trial have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Fibrostenotic Crohn Disease

Drugs mentioned

• SPESOLIMAB (BI655130)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Fibrostenotic Crohn´s Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-06-26